OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-03-31-accounts

REGISTERED CHARITY NUMBER: 1140671

Report of the Trustees and Financial Statements for the Year Ended 31 March 2025

for

Noonan Syndrome Association

Morgan Griffiths LLP Chartered Accountants Cross Chambers

9 High Street Newtown Powys SY16 2NY

Noonan Syndrome Association

Contents of the Financial Statements for the Year Ended 31 March 2025

Page
Reference and Administrative Details 1
Report of the Trustees 2 to 4
Independent Examiner's Report 5
Statement of Financial Activities 6
Balance Sheet 7
Notes to the Financial Statements 8 to 12
Detailed Statement of Financial Activities 13

Noonan Syndrome Association

Reference and Administrative Details for the Year Ended 31 March 2025

TRUSTEES Sharon Allsopp Chair of Trustees Andrea Reid - Kelly Deputy Chair Grayson Bowler Treasurer Michael Patton Medical Adviser (resigned 13.7.24) Brian Carlton Jeanette Dyer Ian Legg Emma Burkitt-Wright Medical advisor (appointed 13.7.24) Susan Miller (appointed 13.8.24) PRINCIPAL ADDRESS The Marshal Room 23-25 Old Row Whalley Road Barrow Lancashire BB7 9AZ REGISTERED CHARITY 1140671 NUMBER INDEPENDENT EXAMINER Morgan Griffiths LLP Chartered Accountants Cross Chambers 9 High Street Newtown Powys SY16 2NY BANKERS CAF Bank Ltd 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ

Charity Manager Sandie Dent Correspondence Address The Marshal Room 23-25 Old Row Whalley Road Barrow Lancashire BB7 9AZ

Page 1

Noonan Syndrome Association

Report of the Trustees for the Year Ended 31 March 2025

The trustees present their report with the financial statements of the charity for the year ended 31 March 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

The objectives of the charity are to provide relief of all persons affected by Noonan Syndrome and related conditions (on the Ras/MAPK pathway) by all or any of the following means:

  1. The provision of general advice, guidance and support services for persons affected by Noonan Syndrome and related conditions (on the Ras/MAPK pathway), their families, dependents and carers;

  2. The facilitation and promotion of research into the causes, effects, diagnosis, treatment and relief of Noonan Syndrome and related conditions (on the Ras/MAPK pathway) with the useful results of research being disseminated for the benefit of the public;

  3. The advancement in the education of the public in relation to the effects of Noonan Syndrome and related conditions (on the Ras/MAPK pathway) by communicating reports and disseminating information by any means or media concerning research work and studies undertaken by or on behalf of the charity.

In all that we do, our trustees have given careful consideration to the Charity Commission's general guidance on public benefit and have complied with the duty in section 4 of the 2011/2006 Charities Act.

ACHIEVEMENTS AND PERFORMANCE

Charitable activities

The Charity entered the year in a stable financial position, though with a recognition that regular giving and fundraising income streams were down on previous years.

During the financial year, the charity's Medical Advisor Trustee and co-founder, Prof. Michael Patton, retired and the charity welcomed Dr Emma Burkitt-Wright as the new Medical Advisor Trustee. Dr Burkitt-Wright has a long-standing relationship with the charity as a member of the Professional Advisory Group.

Sue Miller, a volunteer with a long-standing connection to the charity, also joined the board as a coopted trustee, bringing the total trustees during the 2024-5 year to eight.

Support activities during the year included a Families Day & Conference with renowned guest speakers, themed webinars and updates to the associated factsheet resources, continued support from a wide range of complex member enquiries, production of regular informative newsletters and dissemination of findings from the Living with Noonan Syndrome research project, carried out in collaboration with Loughborough University.

Governance and operational activities included board reviews of the 3 year strategy, including detailed assessment of the cost/benefit of holding large Families and Conference weekend events. The Board is keen to find alternative options, to ensure more cost-effective and inclusive support for members, and a detailed options plan was drawn up to feed into the strategic planning process.

The year presented income generating challenges with a fall in regular giving and difficulties securing grant funding in a challenging funding landscape. Although income was slightly up on the previous year, it is down on earlier years. Strategic planning identified a priority around communications campaigns to support donations and member fundraising, in particular targeted professional campaigns around regular giving, and this is planned as a focus for the coming year.

Page 2

Noonan Syndrome Association

Report of the Trustees for the Year Ended 31 March 2025

FINANCIAL REVIEW

Financial position

The statement of Financial Activities shows a deficit for the year of £33,326 (2024: £17,905), and reserves now stand at £46,560 (2024: £79,886).

Reserves policy

The charity does not have a separate formal policy on Reserves but following Board discussions, the Chair, Treasurer and Charity Manager follow a policy based on achieving free reserves of a minimum of between 3 and 6 months' operating costs including those associated with the cost of a part time charity manager.

The charity has an established and appropriate financial management system which is regularly reviewed by the Board and put into day to day practice by the Charity Manager, Charity Treasurer, Finance Officer together with the Chair of Trustees.

Free reserves which equate to net current assets (excluding restricted funds) amount to £45,472 (2024: £59,278).

FUTURE PLANS

To further strengthen the board and, in particular, seek trustees with experience in finance, marketing and communications where possible to support the strategic plan, including the development of professional fundraising campaigns.

To review and update membership of the Professional Advisory Group to strengthen this resource with the addition of new medical professionals and inclusion of non-medical professionals with expertise valuable to the charity's membership.

Increase in the range of webinar topics, to include small group online support sessions such as an Educational Transitions small group session planned for early 2025-6. To continue providing medical topic webinars, starting with a Growth webinar and updated Growth Factsheet in Q1.

To hold a one-day regional conference with guest speakers and workshop sessions in place of the larger weekend families day event and hold these at locations across the UK, beginning with Manchester in 2025-6.

Create a new Multi-Agency subgroup to focus on non-medical support areas such as education and other social care projects highlighted as important to members. To explore how to provide new and existing support in the most inclusive and cost-effective ways.

Continue to support research projects and the dissemination of the new International guidelines for NS due to be completed in 2025-6. To better understand and develop relationships with other agencies for collaboration, shared dissemination and awareness raising.

STRUCTURE, GOVERNANCE AND MANAGEMENT Governing document

The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity.

Recruitment and appointment of new trustees

Trustees are elected by way of a resolution of the Charity at the Annual General Meeting. The Trustees also have the power at any time, and from time to time, to appoint any person to be a Trustee [subject to certain restrictions], either to fill a casual vacancy or as an addition to the existing members of the Board of Trustees but so that the total number of Trustees does not exceed any maximum number fixed in accordance with this Constitution. Any Trustee so appointed shall hold office only until the next following Annual General Meeting, and shall then be eligible for re-election.

Page 3

Noonan Syndrome Association

Report of the Trustees for the Year Ended 31 March 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT

Organisational structure

The charity is organised so that the trustees meet regularly to manage its affairs. Full Trustee Board meetings are held at least four times per year with other meetings held as required, both face to face and by conference call or internet.

There is an Annual General Meeting held for all the members of the charity at which Trustees are elected or confirmed.

The part time Charity Manager undertakes most of the day to day operations of the charity. In addition to a Chair, the trustees have appointed a Deputy Chair and a Treasurer.

Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. It has an agreed set of financial procedures and policies, practices and guidance to cover its activities, including the reserves policy set out above.

Approved by order of the board of trustees on 24 January 2026 and signed on its behalf by:

Sharon Allsopp - Trustee

Page 4

Independent Examiner's Report to the Trustees of Noonan Syndrome Association

Independent examiner's report to the trustees of Noonan Syndrome Association

I report to the charity trustees on my examination of the accounts of Noonan Syndrome Association (the Trust) for the year ended 31 March 2025.

Responsibilities and basis of report

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Thomas Landers BA FCA

Morgan Griffiths LLP Chartered Accountants Cross Chambers 9 High Street Newtown Powys SY16 2NY

24 January 2026

Page 5

Noonan Syndrome Association

Statement of Financial Activities for the Year Ended 31 March 2025

Unrestricted
Restricted
fund
funds
Notes
£
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
35,598
11,980
Investment income
3
489
-
Total
36,087
11,980
EXPENDITURE ON
Charitable activities
4
Research
6,306
20,000
Support Network
32,132
11,500
Awareness
11,455
-
Total
49,893
31,500
NET INCOME/(EXPENDITURE)
(13,806)
(19,520)
RECONCILIATION OF FUNDS
Total funds brought forward
59,278
20,608
TOTAL FUNDS CARRIED FORWARD
45,472
1,088
31.3.25
31.3.24
Total
Total
funds
funds
£
£
47,578
30,374
489
53
48,067
30,427
26,306
25,677
43,632
11,322
11,455
11,333
81,393
48,332
(33,326)
(17,905)
79,886
97,791
46,560
79,886

The notes form part of these financial statements

Page 6

Noonan Syndrome Association

Balance Sheet 31 March 2025

Notes
CURRENT ASSETS
Debtors
9
Cash at bank
CREDITORS
Amounts falling due within one year
10
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
12
Unrestricted funds
Restricted funds
TOTAL FUNDS
31.3.25
£
3,407
44,123
47,530
(970)
46,560
46,560
46,560
45,472
1,088
46,560
31.3.24
£
28,901
70,396
99,297
(19,411)
79,886
79,886
79,886
59,278
20,608
79,886

The financial statements were approved by the Board of Trustees and authorised for issue on 24 January 2026 and were signed on its behalf by:

Sharon Allsopp - Trustee

The notes form part of these financial statements

Page 7

Noonan Syndrome Association Notes to the Financial Statements for the Year Ended 31 March 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.

Income recognition

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2. DONATIONS AND LEGACIES

Donations
Gift aid
Grants
Grants received, included in the above, are as follows:
Novo Nordisk Limited
Sense - The National Deafblind and Rubella Association
31.3.25
£
33,501
2,577
11,500
47,578
31.3.25
£
3,000
8,500
11,500
31.3.24
£
27,784
2,590
-
30,374
31.3.24
£
-
-
-

Page 8

continued...

Noonan Syndrome Association

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

3.
INVESTMENT INCOME
31.3.25
£
Deposit account interest
54
Other interest
435
489
4.
CHARITABLE ACTIVITIES COSTS
Direct
Support
Costs (see
costs (see
note 5)
note 6)
£
£
Research
25,578
728
Support Network
42,905
727
Awareness
11,154
301
79,637
1,756
5.
DIRECT COSTS OF CHARITABLE ACTIVITIES
31.3.25
£
Postage and stationery
529
Promotional material
84
Family day
31,828
Travel expenses
771
Computer & IT support costs
2,619
Charity Manager
17,933
Research
20,000
Administration costs
5,873
Staff & volunteer training
-
79,637
6.
SUPPORT COSTS
Governance
Finance
costs
£
£
Research
28
700
Support Network
54
673
Awareness
54
247
136
1,620
31.3.24
£
53
-
53
Totals
£
26,306
43,632
11,455
31.3.24
£
53
-
53
Totals
£
26,306
43,632
11,455
81,393
31.3.24
£
1,350
450
-
595
1,949
16,747
20,000
5,388
198
46,677
Totals
£
728
727
301
1,756

Page 9

continued...

Noonan Syndrome Association

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

7. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.

Trustees' expenses

During the year no trustees were reimbursed for travelling expenses ( 2024 - nil).

8. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
30,044
Investment income
53
Total
30,097
EXPENDITURE ON
Charitable activities
Research
5,677
Support Network
11,322
Awareness
11,333
Total
28,332
NET INCOME/(EXPENDITURE)
1,765
RECONCILIATION OF FUNDS
Total funds brought forward
57,513
TOTAL FUNDS CARRIED FORWARD
59,278
9.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade debtors
Accrued income
Prepayments
Restricted
funds
£
330
-
330
20,000
-
-
20,000
(19,670)
40,278
20,608
31.3.25
£
-
2,526
881
3,407
Total
funds
£
30,374
53
30,427
25,677
11,322
11,333
48,332
(17,905)
97,791
79,886
31.3.24
£
10
8,169
20,722
28,901

Page 10

continued...

Noonan Syndrome Association

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25 31.3.24
£ £
Trade creditors - 900
Other creditors 970 18,511
970 19,411
11. ANALYSIS OF NET ASSETS BETWEEN FUNDS
31.3.25 31.3.24
Unrestricted Restricted Total Total
fund funds funds funds
£ £ £ £
Current assets 46,442 1,088 47,530 99,297
Current liabilities (970) - (970) (19,411)
45,472 1,088 46,560 79,886
12. MOVEMENT IN FUNDS
Net
movement At
At 1.4.24 in funds 31.3.25
£ £ £
Unrestricted funds
General fund 59,278 (13,806) 45,472
Restricted funds
Noonan Syndrome Research Fund 10,585 (9,504) 1,081
The Andrew Family Research Fund 10,016 (10,016) -
Support costs 7 - 7
20,608 (19,520) 1,088
TOTAL FUNDS 79,886 (33,326) 46,560
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 36,087 (49,893) (13,806)
Restricted funds
Noonan Syndrome Research Fund 480 (9,984) (9,504)
Families Event 11,500 (11,500) -
The Andrew Family Research Fund - (10,016) (10,016)
11,980 (31,500) (19,520)
TOTAL FUNDS 48,067 (81,393) (33,326)

Page 11

continued...

Noonan Syndrome Association

Notes to the Financial Statements - continued for the Year Ended 31 March 2025

12. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
Restricted funds
Noonan Syndrome Research Fund
The Andrew Family Research Fund
Support costs
TOTAL FUNDS
Comparative net movement in funds, included in the above are
Unrestricted funds
General fund
Restricted funds
Noonan Syndrome Research Fund
TOTAL FUNDS
Net
movement
At
At 1.4.23
in funds
31.3.24
£
£
£
57,513
1,765
59,278
30,255
(19,670)
10,585
10,016
-
10,016
7
-
7
40,278
(19,670)
20,608
97,791
(17,905)
79,886
as follows:
Incoming
Resources
Movement
resources
expended
in funds
£
£
£
30,097
(28,332)
1,765
330
(20,000)
(19,670)
30,427
(48,332)
(17,905)

The Andrew Family Research Fund: This is to fund medical research directly relevant to Noonan Syndrome.

13. RELATED PARTY DISCLOSURES

During the year the trustees made donations to the charity totalling £1,691 2024: £1,440).

Page 12

Noonan Syndrome Association

Detailed Statement of Financial Activities for the Year Ended 31 March 2025

31.3.25 31.3.24
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Donations 33,501 27,784
Gift aid 2,577 2,590
Grants 11,500 -
47,578 30,374
Investment income
Deposit account interest 54 53
Other interest 435 -
489 53
Total incoming resources 48,067 30,427
EXPENDITURE
Charitable activities
Postage and stationery 529 1,350
Promotional material 84 450
Family day 31,828 -
Travel expenses 771 595
Computer & IT support costs 2,619 1,949
Charity Manager 17,933 16,747
Research 20,000 20,000
Administration costs 5,873 5,388
Staff & volunteer training - 198
79,637 46,677
Support costs
Finance
Bank charges 136 61
Governance costs
Indemnity insurance 618 694
Accountancy and legal fees 1,002 900
1,620 1,594
Total resources expended 81,393 48,332
Net expenditure (33,326) (17,905)

This page does not form part of the statutory financial statements

Page 13